The lack of OT‐I bias towards specific regions of the tumour compared with other CD8+ T cells indicates, therefore, that the overall distribution of CD8+ T cells in these tumours can be used as a proxy for those that are truly specific for tumour antigens. The gene discussed is CD8A; the disease is neoplasm.